
PART I FINANCIAL INFORMATION Unaudited Condensed Financial Statements This section presents the unaudited financial statements for Q1 2023, reporting a net loss of $2.53 million and a decrease in total assets Balance Sheets The balance sheet as of March 31, 2023, shows total assets decreased to $17.5 million and stockholders' equity declined Balance Sheet Summary (in thousands) | Account | March 31, 2023 | December 31, 2022 | | :--- | :--- | :--- | | Assets | | | | Cash and cash equivalents | $14,520 | $16,346 | | Total current assets | $15,024 | $16,903 | | Total assets | $17,521 | $19,399 | | Liabilities & Equity | | | | Total current liabilities | $501 | $449 | | Total liabilities | $1,531 | $1,491 | | Total stockholders' equity | $15,991 | $17,909 | Statements of Operations For Q1 2023, the company reported a net loss of $2.53 million, primarily due to increased operating expenses Q1 2023 vs. Q1 2022 Statement of Operations (in thousands) | Metric | Q1 2023 | Q1 2022 | | :--- | :--- | :--- | | Grant Revenue | $0.66 | $125.01 | | Total Operating Expenses | $2,639 | $1,901 | | - Research and Development | $1,440 | $829 | | - General and Administrative | $895 | $853 | | Loss from Operations | ($2,639) | ($1,901) | | Net Loss | ($2,528) | ($1,905) | | Net Loss Per Share | ($0.41) | ($0.31) | Statements of Cash Flows Net cash used in operating activities for Q1 2023 increased to $1.76 million, resulting in a net decrease in cash Q1 2023 vs. Q1 2022 Cash Flow Summary (in thousands) | Metric | Q1 2023 | Q1 2022 | | :--- | :--- | :--- | | Net cash used in operating activities | ($1,756) | ($1,417) | | Net cash used in investing activities | ($69) | ($28) | | Net decrease in cash | ($1,825) | ($1,445) | | Cash at end of period | $14,520 | $21,725 | Statements of Stockholders' Equity Stockholders' equity decreased from $17.9 million to $16.0 million as of March 31, 2023 - Total stockholders' equity decreased from $17,908,604 at December 31, 2022, to $15,990,545 at March 31, 202319 - The decrease in equity was primarily driven by the net loss of $2,527,985, partially offset by stock-based compensation of $609,92619 Notes to Unaudited Financial Statements The notes clarify the company's focus on B-TRAN™ technology, funding, and details on intangible assets and equity - The company is focused on the development and commercialization of its Bidirectional bipolar junction TRANsistor (B-TRAN™) solid-state switch technology22 - Continued operations are dependent on obtaining adequate funding through future revenues, stock offerings, debt financing, or other alternatives23 - The company has a licensing agreement that expires in February 2033 and requires annual payments of $100,00035 - As of March 31, 2023, the company had 786,420 warrants outstanding with a weighted average exercise price of $5.19 and 253,828 pre-funded warrants with an exercise price of $0.00144 Management's Discussion and Analysis of Financial Condition and Results of Operations Management discusses B-TRAN™ technology commercialization, product launch, and a Q1 2023 net loss increase - The company is solely focused on the further development and commercialization of its B-TRAN™ solid-state switch technology53 - In January 2023, the company launched its first commercial product, the SymCool™ Power Module, designed for the solid-state circuit breaker (SSCB) market, with initial sales expected later in 202355 - A product development agreement is in place with a top 10 global automaker for a custom B-TRAN™ power module for use in electric vehicle (EV) drivetrain inverters56 Q1 2023 vs. Q1 2022 Operating Results Comparison (in thousands) | Metric | Q1 2023 (in thousands) | Q1 2022 (in thousands) | Change | | :--- | :--- | :--- | :--- | | Grant Revenue | $0.66 | $125.01 | -99.5% | | R&D Expenses | $1,440.03 | $828.55 | +74% | | Loss from Operations | ($2,639.29) | ($1,900.93) | +39% | | Net Loss | ($2,527.99) | ($1,904.64) | +33% | - As of March 31, 2023, the company had $14.5 million in cash and cash equivalents and believes this will be sufficient to meet liquidity needs for at least the next twelve months6869 Quantitative and Qualitative Disclosures About Market Risk The company states that as a smaller reporting company, it is not required to provide this information - As a smaller reporting company, Ideal Power is not required to provide quantitative and qualitative disclosures about market risk75 Controls and Procedures Management concluded the company's disclosure controls and procedures were effective as of March 31, 2023 - The company's management, including the CEO and CFO, concluded that disclosure controls and procedures were effective as of March 31, 202377 - There were no material changes in the company's internal controls over financial reporting during the quarter ended March 31, 202378 PART II OTHER INFORMATION Legal Proceedings The company reports that it is not currently a party to any legal proceedings - The company is not currently party to any legal proceedings82 Risk Factors The company states there are no material changes from the risk factors disclosed in its Annual Report on Form 10-K - There are no material changes from the risk factors previously disclosed in the company's Annual Report on Form 10-K for the year ended December 31, 202283 Unregistered Sales of Equity Securities and Use of Proceeds The company reports no unregistered sales of equity securities or use of proceeds during the period - None reported for the period84 Defaults Upon Senior Securities This item is not applicable to the company - Not applicable85 Mine Safety Disclosures This item is not applicable to the company - Not applicable86 Other Information The company reports no other information for the period - None reported for the period87 Exhibits This section lists the exhibits filed with the Form 10-Q, including CEO and CFO certifications - The report lists certifications by the Principal Executive Officer and Principal Financial Officer pursuant to Sarbanes-Oxley Act Sections 302 and 906, as well as Inline XBRL documents89